Co-Diagnostics Inc [CODX] moved up 80.76: Why It’s Important

Brandon Evans

Co-Diagnostics Inc [NASDAQ: CODX] traded at a high on 2025-09-16, posting a 80.76 gain after which it closed the day’ session at $0.64.

The results of the trading session contributed to over 240076942 shares changing hands. Over the past one week, the price volatility of Co-Diagnostics Inc stands at 30.12% while the volatility over the past one month is 15.02%.

The market cap for CODX stock reached $24.60 million, with 36.18 million shares outstanding and 35.06 million shares in the current float. Compared to the average trading volume of 2.27M shares, CODX reached a trading volume of 240076942 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Co-Diagnostics Inc [CODX]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CODX shares is $10.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CODX stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Sidoti have made an estimate for Co-Diagnostics Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 12, 2022. While these analysts kept the previous recommendation, Sidoti raised their target price to Buy. The new note on the price target was released on December 29, 2021, representing the official price target for Co-Diagnostics Inc stock.

The Price to Book ratio for the last quarter was 0.56, with the Price to Cash per share for the same quarter was set at 0.35.

How has CODX stock performed recently?

Co-Diagnostics Inc [CODX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 103.31. With this latest performance, CODX shares gained by 117.13% in over the last four-week period, additionally plugging by 41.33% over the last 6 months – not to mention a drop of -14.83% in the past year of trading.

Co-Diagnostics Inc [CODX]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Co-Diagnostics Inc [CODX] shares currently have an operating margin of -6882.12% and a Gross Margin at -231.30%. Co-Diagnostics Inc’s Net Margin is presently recorded at -6321.00%.

Co-Diagnostics Inc (CODX) Capital Structure & Debt Analysis

According to recent financial data for Co-Diagnostics Inc. ( CODX), the Return on Equity (ROE) stands at -63.40%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -56.60%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Co-Diagnostics Inc’s Return on Invested Capital (ROIC) is -85.66%, showcasing its effectiveness in deploying capital for earnings.

Co-Diagnostics Inc (CODX) Efficiency & Liquidity Metrics

Based on Co-Diagnostics Inc’s (CODX) latest financial statements, the Debt-to-Equity Ratio is 0.04%, indicating its reliance on debt financing relative to shareholder equity.

Co-Diagnostics Inc (CODX) Efficiency & Liquidity Metrics

From an operational efficiency perspective, Co-Diagnostics Inc. (CODX) effectively leverages its workforce, generating an average of -$272651.52 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.12% and a Quick Ratio of 3.83%, indicating strong ability to cover short-term liabilities.

Earnings analysis for Co-Diagnostics Inc [CODX]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CODX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Co-Diagnostics Inc go to 37.69%.

Insider trade positions for Co-Diagnostics Inc [CODX]

There are presently around $13.46%, or 14.61%% of CODX stock, in the hands of institutional investors. The top three institutional holders of CODX stocks are: VANGUARD GROUP INC with ownership of 1.78 million shares, which is approximately 5.913%. RENAISSANCE TECHNOLOGIES LLC, holding 0.59 million shares of the stock with an approximate value of $$0.73 million in CODX stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $$0.63 million in CODX stock with ownership which is approximately 1.6665%.

DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.